Guidant is the famous Corporate Investor, which was founded in 1994. The main office of represented Corporate Investor is situated in the Indianapolis. The venture was found in North America in United States.
The important activity for fund was in 2004. Deals in the range of 10 - 50 millions dollars are the general things for fund. The typical startup value when the investment from Guidant is 100-500 millions dollars. Speaking about the real fund results, this Corporate Investor is 5 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. This Guidant works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2008.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Guidant, startups are often financed by Sanderling Ventures, Biofrontier Partners, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Three Arch Partners, Sanderling Ventures, Oxford Bioscience Partners. In the next rounds fund is usually obtained by New Enterprise Associates, Versant Ventures, Three Arch Partners.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most successful fund investment fields, there are Medical Device, Therapeutics. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Intrapace, Bioheart, CardioMEMS.
Related Funds
Fund Name | Location |
Ankang Venture Investment | - |
Balance Ventures | California, San Francisco, United States |
Club Invest 77 | France, Ile-de-France, Serris |
Compuware Ventures | Detroit, Michigan, United States |
Cruttenden Partners | California, Newport Beach, United States |
dtac Accelerate | Bangkok, Krung Thep, Thailand |
Geekdom | Australia, New South Wales, Sydney |
Gojo & Company, Inc. | Japan, Tokyo |
Gollust Management | - |
Highlander Partners | Dallas, Texas, United States |
Jupiter Capital | Bangalore, India, Karnataka |
Masters Capital Nanotechnology | Chicago, Illinois, United States |
Mentha Capital | Amsterdam, Noord-Holland, The Netherlands |
New Directions | Cleveland, Ohio, United States |
RAD Data Communications | Israel, Tel Aviv, Tel Aviv District |
Redbud Capital | - |
Southwest Michigan First | Kalamazoo, Michigan, United States |
Tanium | Kirkland, United States, Washington |
WISENEXT | Lisboa, Lisbon, Portugal |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Remon Medical Technologies | $10M | 10 Jan 2005 | North District | ||
Intrapace | $14M | 14 Jul 2004 | San Jose, California, United States | ||
Evalve | $35M | 25 May 2004 | California, United States | ||
CardioMEMS | $14M | 26 Nov 2003 | Atlanta, Georgia, United States | ||
CardioNet | $13M | 13 Jan 2003 | Pennsylvania, United States | ||
CardioFocus | $1M | 02 Aug 2001 | Marlborough, Massachusetts, United States | ||
CardioFocus | $9M | 06 Jan 2000 | Marlborough, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Remon Medical Technologies | $10M | 10 Jan 2005 | North District | ||
Intrapace | $14M | 14 Jul 2004 | San Jose, California, United States | ||
Evalve | $35M | 25 May 2004 | California, United States | ||
CardioMEMS | $14M | 26 Nov 2003 | Atlanta, Georgia, United States | ||
CardioNet | $13M | 13 Jan 2003 | Pennsylvania, United States | ||
CardioFocus | $1M | 02 Aug 2001 | Marlborough, Massachusetts, United States | ||
CardioFocus | $9M | 06 Jan 2000 | Marlborough, Massachusetts, United States |